XPH — SPDR S&P Pharmaceuticals ETF

—
PCX · Health Care · Developed Markets · CIK ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
No quarterly fundamentals indexed for this ticker.

Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $63.00 · spot: $64.23 · call volume: 109 · put volume: 51

News headlines (Yahoo Finance, 1h cache)

BioNTech May Be the Next Moderna. Even if it Isn’t, the Stock Is a Buy.
2026-11-13 16:17 · Yahoo
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
2026-10-21 09:20 · Yahoo
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
2026-10-08 09:20 · Yahoo
Execution of Pharma Tariffs Brings These ETFs Into Focus
2026-10-06 13:22 · Yahoo
Healthcare ETFs Are Looking Up: Here's Why
2026-08-19 13:00 · Yahoo
These 5 Undervalued ETFs Could Be Bargains Right Now
2026-02-26 12:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.